An 11-year-old boy is brought to the pediatric emergency department due to severe, worsening shortness of breath over the past 24 hours. He has a known history of moderate persistent asthma and has been using his albuterol inhaler every 2 hours at home without relief. On arrival, the patient appears lethargic and diaphoretic. He is only able to speak in single syllables. His temperature is (), pulse is , respirations are , and blood pressure is . Pulse oximetry is on room air. Lung auscultation reveals a "silent chest" with profoundly diminished air entry bilaterally and minimal wheezing.
An arterial blood gas analysis on room air shows:
| Parameter | Value | Reference Range |
|---|---|---|
| pH | ||
| PaO₂ | ||
| PaCO₂ |
Which of the following is the most appropriate next step in management?
- AAdministration of intravenous ceftriaxone and azithromycin
- BAdministration of intravenous sodium bicarbonate
- CAdministration of nebulized hypertonic saline
- Endotracheal intubationAnswer
- EObtaining a computed tomography scan of the chest
Answer
Endotracheal intubation
The correct answer is endotracheal intubation. This patient is in status asthmaticus and exhibiting textbook signs of impending respiratory failure. During an acute asthma exacerbation, increased work of breathing typically leads to hyperventilation and a respiratory alkalosis (low PaCO2). However, as the patient tires and respiratory muscles fatigue, ventilation decreases, leading to a "normalization" or elevation of the PaCO2. In this patient, a PaCO2 of 56 mmHg combined with lethargy, bradypnea (14/min in a severely dyspneic 11-year-old), and a "silent chest" (airflow is too poor to generate wheezing) confirms impending respiratory arrest. The most appropriate immediate intervention is to secure the airway with endotracheal intubation and initiate mechanical ventilation.
Step-by-Step Solution
Key Concept
Recognition of impending respiratory failure in status asthmaticus, indicated by altered mental status, a 'silent chest', and a normal or elevated PaCO2.